Medical News

RSS

Spinifex secures AU$6.25 million in expanded Series B funding

Spinifex Pharmaceuticals, an Australian pain drug development company, today announced it has secured a further AU$6.25 million of venture capital investment from GBS Venture Partners Limited, Brandon Capital Partners Pty Limited, Uniseed Management Pty Limited and UniQuest Pty Limited to fund the development of its pain management drug, EMA401.

23 Aug 2011

Study: More attention needs to be paid for cartilage during RA diagnosis

This could lead to a paradigm shift in the treatment of rheumatoid arthritis: rheumatologists at the Medical University of Vienna have discovered, through a secondary study involving 3,000 female patients, that the condition of the cartilage in inflammatory joint rheumatism needs to be paid more attention than has previously been the case. Until now, the focus lay mainly on investigating the damage to the bone.

23 Aug 2011

KU researcher investigates impact of joblessness on masculinity

The acute economic downturn that began in 2008 sometimes is called the "mancession" to reflect its harsher impact on men than women. As recently as last November, 10.4 percent of adult men were unemployed as compared to 8 percent of adult women.

23 Aug 2011

Cambridge Memorial Hospital installs Toshiba's CT and ultrasound system

Since quick and accurate diagnosis is critical in an acute setting, Cambridge Memorial Hospital, a critical care hospital in Nebraska operating as part of the integrated Tri Valley Health System, has installed the Aquilion 64 CT system and the Aplio XG ultrasound system from Toshiba America Medical Systems, Inc.

23 Aug 2011

RMS opens new Innovation Center, updated medical solution testing facility

Rubbermaid Medical Solutions (RMS), the leading provider of medication carts and mobile computing solutions for healthcare facilities, announced the opening of its new Innovation Center and updated testing facility today.

23 Aug 2011

NextDocs receives $10.3 million in Series A financing

NextDocs Corporation, the global leader in Microsoft SharePoint based software solutions for life sciences industries, today announced that the Company has received $10.3 million in a Series A financing from OpenView Venture Partners.

23 Aug 2011

New EHNAC accreditation program for HIE technology service providers

The Electronic Healthcare Network Accreditation Commission (EHNAC), a non-profit standards development organization and accrediting body, announced today the development of Outsourced Services Accreditation Program for Health Information Exchange Services (OSAP-HIE), a new accreditation program offering for health information exchange (HIE) technology service providers.

23 Aug 2011

Crimson announces publication of Japan Medical Device Digest

Crimson Life Sciences, a division of TransPerfect and the world's only ISO 13485 and ISO 14971-certified translation provider, today announced the publication of their Japan Medical Device Digest, a free monthly report that provides English translations of Japanese-language news items.

23 Aug 2011

Molecular Endocrinology journal publishes two studies on estrogen hormones

University of Houston (UH) researchers have their sights set on developing possible treatments for breast and colon cancer.

23 Aug 2011

USAID helps improve maternal, child health care at Pakistani hospital

This post in the State Department's "DipNote" blog looks at Fatima Jinnah Women's Hospital, "one of more than 80 Pakistani medical facilities that the United States has helped renovate in recent years in Pakistan" and describes how medical personnel at the facility "demonstrated the benefits that new equipment and training opportunities have made to their standard of care on Thursday, August 18, as U.S. Agency for International Development Mission Director Andrew Sisson toured the facility."

23 Aug 2011

CVS Caremark announces results of Consent Solicitation from registered holders

CVS Caremark Corporation announced today the results of its previously announced solicitation of consents from the registered holders as of 5:00 p.m., New York City time on August 8, 2011 of its 6.125% Senior Notes due August 15, 2016 to terminate the replacement capital covenant, which was entered into on May 25, 2007, for the benefit of the holders of the Notes in connection with the issuance of its 6.302% Enhanced Capital Advantaged Preferred Securities due 2062.

23 Aug 2011

CompTIA to offer live healthcare IT training sessions in Los Angeles, Chicago

Training programs designed to help information technology (IT) companies broaden their business skills and knowledge in the emerging areas of healthcare IT and unified communications are available in the coming weeks from CompTIA, the non-profit association for the IT industry.

23 Aug 2011

Aptiv Solutions acquires Medical Device Consultants

Aptiv Solutions announced today the acquisition of Medical Device Consultants, Inc. (MDCI), a provider of expert medical device consulting and clinical trial management and execution.

23 Aug 2011

OICR President announces $12.6M in funding for High Impact Clinical Trials Program

Dr. Tom Hudson, President and Scientific Director of the Ontario Institute for Cancer Research (OICR), today announced $12.6 million in funding over four years for OICR's High Impact Clinical Trials (HICT) Program.

23 Aug 2011

UNICEF warns Horn of Africa 'crisis will get worse'; China contributes $16M in aid funds to WFP

UNICEF Executive Director Anthony Lake told reporters on Friday that "more than 300,000 children in the Horn of Africa are severely malnourished 'and in imminent risk of dying' because of drought and famine," the Associated Press/Washington Post reports.

23 Aug 2011

Nepstar second quarter revenue increases 7.3% to US$93.8 million

China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the second quarter ended June 30, 2011.

23 Aug 2011

Symphogen initiates Sym004 Phase 2 trial in squamous cell carcinoma of head and neck cancer

Symphogen A/S today announced the initiation of a Phase 2 clinical trial to investigate the safety and efficacy of Sym004 in patients who have failed anti-EGFR monoclonal antibody (mAb)-based therapy, with recurrent and/or metastatic squamous cell carcinoma of the head and neck.

23 Aug 2011

Radium-223 chloride granted FDA Fast Track designation for treatment of CRPC

Algeta ASA, a company focused on the development of novel targeted cancer therapeutics, today announced that radium-223 chloride has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of castration-resistant (hormone refractory) prostate cancer in patients with bone metastases.

23 Aug 2011

Research into TB medication may shorten treatment regimen

Research of the common tuberculosis (TB) drug pyrazinamide, which is used in combination with other medications to treat the disease in a six-month regimen, "has now revealed that the drug does kill the latent form of the microbe, which does not cause observable symptoms," VOA News reports.

23 Aug 2011

Survival for patients with HCC increases with radioembolization

Analysis revealed survival for patients with hepatocellular carcinoma (HCC) is achievable using 90Y-resin microsphere radioembolization. The analysis conducted at multiple centers across Europe showed that the procedure is likely to provide survival benefit across different tumor stages, including patients with advanced liver cancer and with limited treatment options.

23 Aug 2011